New hip implant studied for better mobility and safety

NCT ID NCT06359301

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 49 people who are getting a total hip replacement with a special device called the DELTA Revision cup. The goal is to see how safe and effective the implant is by measuring hip function, movement, and survival of the implant over two years. Participants are adults with hip osteoarthritis who have already decided to have this surgery as part of their routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DELTA Revision acetabular cup (a medical device used in hip replacement surgery)
What this could lead to
If successful, this study could confirm that the DELTA Revision cup is a safe and effective option for hip replacement, helping patients with hip osteoarthritis regain mobility and reduce pain.
What could go wrong
This is a small, observational study with only 49 participants and no comparison group, so results may not apply to everyone. As with any surgery, risks include infection, implant failure, or complications from anesthesia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP

    RECRUITING

    Otwock, 05-400, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.